Autonomix Medical, Inc. (AMIX) vs bioAffinity Technologies, Inc. (BIAF)
A side-by-side comparison of Autonomix Medical, Inc. and bioAffinity Technologies, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AMIX
Autonomix Medical, Inc.
$3.54HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
BIAF
bioAffinity Technologies, Inc.
$6.19HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — AMIX vs BIAF
growth of $100 · dividends reinvested · last 3yAMIX -99.8% (-88.2%/yr)BIAF -99.1% (-79.5%/yr)BIAF compounded faster over this window
Log scale — wide-divergence pair
AMIX BIAF
AMIX vs BIAF: by the numbers
- •BIAF is the larger company ($3M vs $2M market cap).
- •Both run net losses; AMIX's is the smaller (0.00% vs -257.33% net margin).
Metrics side by side
Valuation
| Metric | AMIX | BIAF |
|---|---|---|
| P/S ratio | N/A | 0.44 |
| P/B ratio | 0.61 | 0.69 |
Profitability
| Metric | AMIX | BIAF |
|---|---|---|
| Gross margin | 0.00% | 23.21% |
| Operating margin | 0.00% | -171.58% |
| Net margin | 0.00% | -257.33% |
| ROE | -509.36% | -402.92% |
| ROIC | -518.15% | -237.93% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.